New Drug Application News and Research

RSS
Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients

Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

FDA approves first generic glucagon for injection to treat severe hypoglycemia

FDA approves first generic glucagon for injection to treat severe hypoglycemia

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Study shows metformin can significantly reduce COVID-19 death risks in women

Study shows metformin can significantly reduce COVID-19 death risks in women

Researchers validate new radiolabeled molecule used in imaging tests to detect brain injury

Researchers validate new radiolabeled molecule used in imaging tests to detect brain injury

COVID-19 vaccine candidate shows potent immune response

COVID-19 vaccine candidate shows potent immune response

Investigational antidepressant PT150 shows antiviral activity against SARS-CoV-2

Investigational antidepressant PT150 shows antiviral activity against SARS-CoV-2

Researchers discover novel class of safer analgesics

Researchers discover novel class of safer analgesics

New vitamin K-based drug eliminates medication-resistant epileptic seizures in mice

New vitamin K-based drug eliminates medication-resistant epileptic seizures in mice

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

Octapharma extends support for COVID-19 study following promising preliminary data

Octapharma extends support for COVID-19 study following promising preliminary data

USAMRDC receives FDA marketing approval for severe malaria treatment

USAMRDC receives FDA marketing approval for severe malaria treatment

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Investigational oral form of treatment offers hope for adults with acromegaly

Investigational oral form of treatment offers hope for adults with acromegaly

FDA approves immune-modulating therapy for treatment of multiple sclerosis

FDA approves immune-modulating therapy for treatment of multiple sclerosis

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

Mayo Clinic researchers seek radical new approach to treat cocaine addition

Mayo Clinic researchers seek radical new approach to treat cocaine addition